Planned phase III trial of recombinant factor VIIa in the treatment of congenital haemophilia A or B in paediatric patients with inhibitors to factor VIII or IX.

Trial Profile

Planned phase III trial of recombinant factor VIIa in the treatment of congenital haemophilia A or B in paediatric patients with inhibitors to factor VIII or IX.

Planning
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2015

At a glance

  • Drugs Recombinant factor VIIa (Primary)
  • Indications Haemophilia A; Haemophilia B
  • Focus Therapeutic Use
  • Acronyms PERSEPT 2
  • Sponsors LFB
  • Most Recent Events

    • 24 Mar 2015 An independent Data Monitoring Committee has concluded that interim data from the PERSEPT 1 trial support the initiation of this trial, according to an LFB media release.
    • 24 Mar 2015 Planned initiation date changed from 1 Mar 2015 to 1 Dec 2015, as reported in an LFB media release.
    • 05 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top